News

Without an FDA approved drug in the last decade, investigators have found ways to improve diagnostics for patients suffering from Alzheimer disease.

An assessment of metoprolol in older patients with COPD had to be discontinued after treated patients reported a greater rate of hospitalization due to exacerbations.

The ID-Cap System represents the only ingestible event marker able to transmit digital data within the body to an external receiver without direct skin contact.

Arjun Masurkar, MD, PhD, discusses some of the issues with Alzheimer disease clinical trials.

A new sponsor will award a Massachusetts-based organization up to $25,000.

Arjun Masurkar, MD, PhD, discusses how genetic testing could usher in a new wave of diagnostics for Alzheimer disease.

The differences between thoughtful and intuitive decision-making, and how it shapes patient care.

The approval makes it the first indicated by the FDA for cardiovascular risk reduction among patients with elevated triglyceride levels, as an add-on to maximally tolerated statin therapy.

In March 2020, the therapy has the potential to become the first approved for the rare autoimmune disorder.

The authorization could allow other technology for diabetes to go through the review process more quickly.

The new indication will allow the longtime ALS therapy to be used among the 85% of patients required to use PEG due to dysphagia.

The once-daily therapy has been previously approved for treatment of adults with difficult-to-treat rheumatoid arthritis or psoriatic arthritis.

System usability scale scores decreased for 44% of vendors from 2014–2015.

The tool provided accurate information for ambulatory procedures, from costs to additional services.

The approval comes 4 months following a Complete Response Letter was submitted and successfully disputed, to Sarepta Therapeutics.

In a new study, investigators suggest coffee may be used in prevention strategies for chronic kidney disease.

The Senate voted 72-18 to support the successor to Scott Gottlieb, MD, following a November hearing which raised questions to his stance on proposed tobacco and e-cigarette policies.

The FDA has granted marketing authorization for the GSP Neonatal Creatine Kinase-MM to aid physicians in screening newborns for Duchenne Muscular Dystrophy.

Investigators show how sleep deprivation has a cognitive impact the following day.

A novel, multichannel AI model outperformed 3 single-channel models in a randomized trial.

A look back at how chronic disease management, physician shortage, and newer therapies shaped the modern care team.

A meta-analysis of more than 1 million patients and 2 dozen studies has revealed patients over 60 with hypothyroidism were at a 26% greater chance of all-cause mortality.

In a comparison, investigators find that surgery is more successful in treating GERD patients who do not respond to protein pump inhibitors.

An analysis of the Dongfeng-Tongi cohort has revealed sleeping more than 9 hours per night or taking midday naps lasting longer than 90 minutes was associated with an increase in risk of total stroke.

The platform could allow clinicians to provide more individualized care to patients.

How primary care fits into the scheme of patient management, and what new therapies may mean for atopic dermatitis.

A study from SUNY University at Buffalo has found adherence to a Western diet could contribute to the development of late age-related macular degeneration.

A new study of more than 60,000 individuals over the course of a decade suggests non-Hispanic blacks were less likely to use and see benefits from low-dose aspirin in the same way as non-Hispanic whites.